Get the Stockscreener App
30.45
0.81%
-0.2497
After Hours:
30.47
0.0247
+0.08%
Tema Heart Health Etf stock is traded at $30.45, with a volume of 3,525.
It is down -0.81% in the last 24 hours and up +8.73% over the past month.
See More
Previous Close:
$30.70
Open:
$30.63
24h Volume:
3,525
Relative Volume:
0.48
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.41%
1M Performance:
+8.73%
6M Performance:
+2.47%
1Y Performance:
-11.23%
1-Day Range:
$30.45
$30.74
1-Week Range:
$30.28
$30.77
52-Week Range:
$25.32
$35.53
Tema Heart Health Etf Stock (HRTS) Company Profile
Name
Tema Heart Health Etf
Sector
Industry
Phone
-
Address
-
Compare HRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTS
Tema Heart Health Etf
|
30.45 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
324.31 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
657.41 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.72 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.41 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
586.66 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Heart Health Etf Stock (HRTS) Latest News
Tema Launches International Durable Quality ETF (ITOL) - Yahoo Finance
Medtronic Plummets 4.2% on Earnings Optimism Overshadowed by Activist Investor Moves - AInvest
The stock price of Novo-Nordisk A/S plummeted by nearly 22%; what happened? - 富途牛牛
Short Interest in Tema Heart & Health ETF (NASDAQ:HRTS) Decreases By 62.5% - Defense World
OFS Credit Company, Inc. (NASDAQ:OCCIN) Sees Significant Decline in Short Interest - Defense World
Northern Graphite (CVE:NGC) Shares Up 42.1% – Time to Buy? - Defense World
Tema Announces Liquidation of Two ETFs - Yahoo Finance
5 Small-cap Biotech ETFs to Watch - Investing News Network
How to Invest in GLP-1 Stocks - The Motley Fool
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY - Investing News Network
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Short Interest in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Declines By 28.6% - Defense World
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Why the Rich World Is Going to Need AI and Africa - Bloomberg.com
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Tema's New VOLT ETF Sparked by AI Revolution - Yahoo Finance
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Nasdaq
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tap the Weight-Loss Drug Market With These ETFs - Nasdaq
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says - CNBC
Disruptive Theme of the Week: The Rise of Active Thematic ETFs - ETF Trends
HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside - Seeking Alpha
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO - markets.businessinsider.com
This ETF is trying to satisfy appetites for weight loss stocks - CNBC
ETF IQ: Mutual Fund Managers Have the Luxury to Just Say ‘No’ - Bloomberg
Investing in the diabesity epidemic: a breakthrough moment | Opto - CMC Markets
Obesity Market to Reach $150B as Demand Grows, Supply Stabilizes: Reuters - BioSpace
Weight-loss drug forecasts jump to $150 billion as supply grows - Reuters
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
Fighting Obesity Using ETFs - ETF Trends
S&P 500: April Selloff Could Be a Very Good Thing for the Months Ahead - Investing.com India
IBD Stock Of The Day Pops After Obesity Drug Crushes Sales Views - Investor's Business Daily
What Is a Healthcare ETF? Everything You Need to Know - ETF.com
The 5 Best Biotech ETFs of 2024 - ETF.com
This weight-loss ETF has performed well. Here’s a look at other options. - MarketWatch
First Weight Loss ETF from Tema ETFs Announces Name Change, Tops $50 Million AUM - Markets Insider
Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss - Investor's Business Daily
Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering - Value The Markets
Tema Launches Third Medical-Themed ETF - FA Mag
The Truth HRTS - TheStreet
LLY Stock: Study Highlights Weight Regain Risk with Lilly's Zepbound - Value The Markets
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade - MarketWatch
A new ETF will allow investors to cash in on the Ozempic-fueled weight loss craze that's swept markets this year - markets.businessinsider.com
Inside Tema ETFs' New Oncology ETF (CANC) - Yahoo Finance
Tema’s Maurits Pot Talks New Luxury and Reshoring ETFs and the Active Approach - Yahoo Finance
Tema Heart Health Etf Stock (HRTS) Financials Data
There is no financial data for Tema Heart Health Etf (HRTS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.61%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):